Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2.
Huang Y, Yu SH, Zhen WX, Cheng T, Wang D, Lin JB, Wu YH, Wang YF, Chen Y, Shu LP, Wang Y, Sun XJ, Zhou Y, Yang F, Hsu CH, Xu PF.
Huang Y, et al. Among authors: wang yf, wang y, wang d.
Theranostics. 2021 May 8;11(14):6891-6904. doi: 10.7150/thno.53170. eCollection 2021.
Theranostics. 2021.
PMID: 34093860
Free PMC article.